Form 144: 5,145 CLPT Shares Proposed for Sale

Morgan Stanley Smith Barney LLC submitted a Form 144 notice reporting the proposed sale of 5,145 shares of Common Stock.

Rhea-AI Filing Summary

Morgan Stanley Smith Barney LLC submitted a Form 144 notice reporting the proposed sale of 5,145 shares of Common Stock. The filing lists an aggregate value of $62,611.56 and reports 29,989,563 shares outstanding as of 06/01/2026 as context. The shares arose from restricted stock vesting under a registered plan on 05/20/2026.

Insights

Securities Compliance Counsel

Form 144 filed for a compensation-related sale of vested restricted stock.

The filing identifies 5,145 shares proposed for sale and characterizes the shares as resulting from restricted stock vesting under a registered plan on 05/20/2026. Form 144 is a notice of intent to sell and does not itself execute a transaction.

Timing and execution details are not provided; subsequent trade reports or broker disclosures would show actual sale completion.

Equity Compensation Analyst

Vesting produced a modest taxable event; sale size is small relative to outstanding shares.

The filing lists an aggregate value of $62,611.56 for 5,145 shares, implying compensation-originated shares being registered for sale. The filing notes 29,989,563 shares outstanding as of 06/01/2026, providing scale for the potential dilution or overhang.

Cash-flow treatment is not stated; the entry identifies the source as compensation.

Key Figures

Shares proposed for sale: 5,145 shares Aggregate value reported: $62,611.56 Shares outstanding: 29,989,563 shares +2 more

5 metrics

Shares proposed for sale 5,145 shares listed in Form 144

Aggregate value reported $62,611.56 Form 144 aggregate value for 5,145 shares

Shares outstanding 29,989,563 shares as of 06/01/2026

Vesting date 05/20/2026 restricted stock vesting under a registered plan

Form date / exchange 06/01/2026 / NASDAQ filing date and exchange listed on Form 144

Key Terms

Form 144, restricted stock vesting, registered plan

3 terms

Form 144 regulatory

"144: Securities To Be Sold"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

restricted stock vesting financial

"Restricted stock vesting under a registered plan"

Restricted stock vesting is the timetable and conditions under which shares granted to employees or insiders become fully owned and can be sold, typically requiring continued work or meeting performance goals. It matters to investors because large blocks of shares can become tradable at once, which can change share supply and price, and because vesting aligns insiders’ incentives with the company’s long‑term performance—think of it like a timed unlock that both rewards and locks in key people.

registered plan regulatory

"Restricted stock vesting under a registered plan"

A registered plan is a savings or investment account that a government recognizes for special tax treatment and rules, such as limits on how much you can put in and conditions for withdrawals. For investors it matters because those rules change how much of your gains are taxed, how quickly your money can be accessed and what strategies make sense — like a labeled jar that gives tax breaks but comes with rules about when and how you can take the money out.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the CLPT Form 144 report?

It reports the proposed sale of 5,145 common shares resulting from restricted stock vesting on 05/20/2026. The filing is a notice of intent, not proof that trades have settled.

How much value is involved in the proposed sale on the Form 144 for CLPT?

The filing lists an aggregate value of $62,611.56 for the 5,145 shares. This figure appears in the Form 144 summary and is the value reported by the filer.

Who is the filer on the CLPT Form 144 and what was the source of shares?

The filer is Morgan Stanley Smith Barney LLC. The shares were reported as arising from restricted stock vesting under a registered plan with the issuer noted as the source.

Does the Form 144 show the shares outstanding for CLPT?

Yes; the filing lists 29,989,563 shares outstanding as of 06/01/2026. This provides context but is not the amount being registered for sale.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/01/2026 - 04:07 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001601831
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	ClearPoint Neuro, Inc.
SEC File Number	001-34822
Address of Issuer	120 S. Sierra Ave., Suite 100 Solana Beach CALIFORNIA 92075
Phone	888-287-9109
Name of Person for Whose Account the Securities are To Be Sold	TIMOTHY RICHARDS
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	5145	62611.56	29989563	06/01/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	05/20/2026	Restricted stock vesting under a registered plan	Issuer			5145	05/20/2026	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	06/01/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Timothy Richards
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)